Yunlang Cai

1.1k total citations · 1 hit paper
33 papers, 728 citations indexed

About

Yunlang Cai is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Yunlang Cai has authored 33 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Reproductive Medicine and 8 papers in Oncology. Recurrent topics in Yunlang Cai's work include Endometriosis Research and Treatment (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer Research and Treatments (4 papers). Yunlang Cai is often cited by papers focused on Endometriosis Research and Treatment (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer Research and Treatments (4 papers). Yunlang Cai collaborates with scholars based in China, Bangladesh and United States. Yunlang Cai's co-authors include Mulan Ren, Di Wu, Yuanjin Zhao, Feng Xu, Yongxing Gao, Peilin Huang, Xiaoqiang Tian, Minli Li, Changmin Shao and Yuxiao Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Lancet Oncology.

In The Last Decade

Yunlang Cai

31 papers receiving 723 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

2021 131 citations Tingyan Shi, Jianqing Zhu et al. The Lancet Oncology profile →

Peers

Yunlang Cai

ONCOL

SURGE

Shu Soeda Japan

Chiao‐Yun Lin Taiwan

Kanako Nanbu Japan

Yuh-Cheng Yang Taiwan

Takashi Mitamura Japan

Huimin Bai China

Zhumei Cui China

Sophie Espenel France

Pengpeng Qu China

Yung‐Kwei Soong Taiwan

Shu Soeda Japan

Yunlang Cai

144 ×0.6

163 ×0.7

205 ×1.3

ONCOL

106 ×0.7

86 ×0.6

SURGE

Citations per year, relative to Yunlang Cai Yunlang Cai (= 1×) peers Shu Soeda

Countries citing papers authored by Yunlang Cai

Since Specialization

Citations

This map shows the geographic impact of Yunlang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunlang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunlang Cai more than expected).

Fields of papers citing papers by Yunlang Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunlang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunlang Cai. The network helps show where Yunlang Cai may publish in the future.

Co-authorship network of co-authors of Yunlang Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Yunlang Cai. A scholar is included among the top collaborators of Yunlang Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunlang Cai. Yunlang Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Yunlang, et al.. (2023). Fast Design of Metasurface-based Microwave Absorber Using the Neuro-TF Approach. 2026–2030.

Xu, Hui, Fengshu Zhao, Di Wu, et al.. (2023). Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination. Biomedicine & Pharmacotherapy. 161. 114547–114547. 8 indexed citations

Ji, Xuan, et al.. (2023). Association between gut microbiota and endometriosis: a two-sample Mendelian randomization study. Frontiers in Microbiology. 14. 1188458–1188458. 8 indexed citations

Li, Xiaocui, et al.. (2022). CSF-1-induced DC-SIGN+ macrophages are present in the ovarian endometriosis. Reproductive Biology and Endocrinology. 20(1). 48–48. 5 indexed citations

Zhu, Xiulin, Di Wu, Li Xu, et al.. (2022). IL-6 secretion of CD4+ T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer. Clinical & Translational Oncology. 24(11). 2222–2230. 6 indexed citations

Shi, Tingyan, Jianqing Zhu, Yanling Feng, et al.. (2021). Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. 22(4). 439–449. 131 indexed citations breakdown →

Chen, Yongqiang, Pengcheng Li, Ning Pan, et al.. (2019). Tumor-released autophagosomes induces CD4+ T cell-mediated immunosuppression via a TLR2–IL-6 cascade. Journal for ImmunoTherapy of Cancer. 7(1). 178–178. 46 indexed citations

Shi, Tingyan, Rong Jiang, Hong Pu, et al.. (2019). Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study. British Journal of Cancer. 121(5). 425–428. 11 indexed citations

Cai, Yunlang, Yunru Yu, Yuxiao Liu, et al.. (2018). Porous scaffolds from droplet microfluidics for prevention of intrauterine adhesion. Acta Biomaterialia. 84. 222–230. 74 indexed citations

10.

Ding, Bo, Wei Sun, Suping Han, et al.. (2018). Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk. Medicine. 97(13). e0210–e0210. 21 indexed citations

11.

Guo, Xin Dong, et al.. (2017). Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells. Oncology Reports. 38(3). 1442–1450. 13 indexed citations

12.

Wang, Shizhi, Shenshen Wu, Haixia Zhu, et al.. (2016). PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population. Scientific Reports. 6(1). 23465–23465. 12 indexed citations

13.

Shen, Yang, Xiaoyu Zhang, Xi Chen, Mulan Ren, & Yunlang Cai. (2016). Octreotide reverses the resistance of A2780/Pacliaxel ovarian cancer cell line to paclitaxel chemotherapy in vitro. Journal of Cancer Research and Therapeutics. 12(2). 657–662. 7 indexed citations

14.

Wu, Di, Jing Wang, Yunlang Cai, et al.. (2015). Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine. Journal of Ovarian Research. 8(1). 68–68. 24 indexed citations

15.

Cai, Yunlang, Jingmei Wang, Di Wu, et al.. (2014). Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer. Medical Oncology. 32(1). 391–391. 101 indexed citations

16.

Ren, Mulan, et al.. (2014). An evidence in vitro for the influence of bisphenol A on uterine leiomyoma. European Journal of Obstetrics & Gynecology and Reproductive Biology. 178. 80–83. 19 indexed citations

17.

Ding, Bo, Wei Sun, Suping Han, Yunlang Cai, & Mulan Ren. (2014). Polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) and endometriosis risk: a meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 183. 114–120. 6 indexed citations

18.

Shen, Yang, Mulan Ren, Feng Xu, et al.. (2014). Does nonylphenol promote the growth of uterine fibroids?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 178. 134–137. 10 indexed citations

19.

Ren, Mulan, et al.. (2014). A Multicenter Case-Control Study on Screening of Single Nucleotide Polymorphisms in Estrogen-Metabolizing Enzymes and Susceptibility to Uterine Leiomyoma in Han Chinese. Gynecologic and Obstetric Investigation. 77(4). 224–230. 12 indexed citations

20.

Shen, Yang, et al.. (2011). Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro. Experimental and Therapeutic Medicine. 2(6). 1171–1176. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact